Project Details
Description
A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children with Central precocious Puberty
| Status | Finished |
|---|---|
| Effective start/end date | 10/15/08 → 12/31/20 |
Funding
- ABBOTT LABORATORIES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.